Lung Cancer Clinical Trial
Official title:
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
NCT number | NCT05526573 |
Other study ID # | 4393 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | July 14, 2022 |
Est. completion date | December 31, 2025 |
The use of an ultrathin bronchoscope (UB) has recently been introduced in the diagnosis of peripheral lung lesions. The use of the UB can be supported by navigation systems such as fluoroscopy, ultrasound guidance, electromagnetic navigation, or other technologies, which have complementary potential. Further navigation techniques are still under study. The use of ultrathin instrumentation has already been shown to significantly reduce procedural times compared to traditional instrumentation. The purpose of the study is to prospectively evaluate the institutional experience of different third-level hospital centers with the use of a UB (MP190F; Olympus Medical Systems, Tokyo, Japan) for sampling peripheral lung lesions by means of transbronchial needle aspiration (TBNA) or transbronchial biopsy (TBB), performed after fluoroscopic navigation and simultaneous radial probe-endobronchial ultrasound (RP-EBUS) assessment. Design: multicentric, observational study.
Status | Recruiting |
Enrollment | 148 |
Est. completion date | December 31, 2025 |
Est. primary completion date | July 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion criteria: - Candidate for a diagnostic procedure for a new peripheral lung lesion or re-biopsy; - Tissue sampling of the peripheral lesion performed only with UB; - The patient's ability to understand the individual characteristics and consequences of the clinical study; - Males and females of any ethnicity; - Subjects who have given their informed consent to use their clinical data for research purposes. Exclusion criteria: - Inability to give informed consent or understand its contents; - Unavailability of tomographic imaging; - Failure to use RP-EBUS or fluoroscopic guidance during the procedure; - Failure to use R.O.S.E. by the pulmonologist or pathologist during the procedure; - Tissue sampling on the same peripheral lesion using an instrument of a different caliber in replacement or in association; - Any other significant illness or disorder that, in the investigator's opinion, may put the patient at risk due to study participation. |
Country | Name | City | State |
---|---|---|---|
Italy | Pneumologia, Azienda Ospedaliero-Universitaria Ospedali Riuniti | Ancona | |
Italy | Pneumologia, Arcispedale S. Maria Nuova | Reggio Emilia | |
Italy | Pneumologia, ASUFC, Az. Osp. Santa Maria della Misericordia | Udine |
Lead Sponsor | Collaborator |
---|---|
Azienda Sanitaria-Universitaria Integrata di Udine |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate the overall diagnostic accuracy | Sensitivity, specificity, positive predictive value, negative predictive value | Within 12 months from the procedure | |
Secondary | Agreement between the definitive pathological result and the rapid on-site evaluation (R.O.S.E.) | Comparison (% of concordant and % of discordant results) between R.O.S.E. (performed during the procedure by the pulmonologist or by the pathologist) and the final result obtained after the evaluation (by the pathologist) of the samples taken. | Within 15 days from the procedure | |
Secondary | Evaluation of patient satisfaction at the end of the procedure (Likert scale in relation to the memory of the procedure and the willingness to repeat it in the future.) | Patients will undergo two satisfaction questionnaires, set according to Likert scale, at the end of the endoscopic procedure. | Same day of the procedure | |
Secondary | Correlation between the type of anesthesia, the characteristics of the lesion, the procedural dynamics and diagnostic accuracy | Within 12 months from the procedure | ||
Secondary | Correlation between the type of anesthesia, the characteristics of the lesion, the procedural dynamics and patient satisfaction | Correlations will be made between the anesthetic, radiological and procedural parameters with respect to the answers obtained in the satisfaction questionnaires. | Same day of the procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|